[HTML][HTML] How to deal with vaccine hesitancy?

J Eskola, P Duclos, M Schuster, NE MacDonald - Vaccine, 2015 - Elsevier
Based on the concerns about vaccine hesitancy and its impact on vaccine uptake rates and
the performance of national immunization programmes, the Strategic Advisory Group of …

Human papillomavirus vaccine trials and tribulations: vaccine efficacy

NS Handler, MZ Handler, S Majewski… - Journal of the American …, 2015 - Elsevier
As of December 2014, there were 3 approved vaccines for human papillomavirus (HPV):
bivalent Cervarix (GlaxoSmithKline, New York, NY), quadrivalent Gardasil (Merck and Co …

[HTML][HTML] Addressing issues of vaccination literacy and psychological empowerment in the measles-mumps-rubella (MMR) vaccination decision-making: a qualitative …

M Fadda, MK Depping, PJ Schulz - BMC Public Health, 2015 - Springer
Background Whether or not to vaccinate one's child is one of the first health-related
decisions parents have to make after their child's birth. For the past 20 years, the share of …

A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan

T Tanimoto - Drug Design, Development and Therapy, 2015 - Taylor & Francis
The universal health care system in Japan is facing a historical turning point as a result of
the increasing fiscal burden, rapidly aging society, and a decreasing population. To …

[PDF][PDF] Knowledge on human papillomavirus-related conditions and determinants of hpv vaccine uptake for cancer prevention among japanese university students …

SM Muchanga, NR Ngatu, R Hirota… - J Vaccines …, 2015 - researchgate.net
Objectives Human papillomavirus (HPV) causes an infection that is related to nearly 99% of
cervical cancer cases. The World health organization (WHO) estimates that there is an …